Yadav, Rashi
Redmond, William L. http://orcid.org/0000-0002-2572-1731
Article History
Accepted: 26 January 2022
First Online: 29 March 2022
Declarations
:
: Yadav: No competing interests. Redmond: Research support from Bristol Myers Squibb, GlaxoSmithKline, MiNA Therapeutics, Inhibrx, Galectin Therapeutics, Veana Therapeutics, Shimadzu, OncoSec, and Calibr. Patents/Licensing Fees: Galectin Therapeutics. Advisory Boards: Medicenna, Vesselon.
Free to read: This content has been made available to all.